Exfoliative dermatitis - Dermatitis Exfoliative
☆ AI Dermatology — Free Service
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Red (burning) Skin Syndrome – erythema sy mizana manerana ny vatana manontolo dia soritr'aretina lehibe amin'ny Dermatitis Exfoliative (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma dia aretin‑koditra tsy fahita firy nefa tena matotra. Na dia tsy fantatra matetika aza ny tena antony, dia mety ho vokatry ny fanehoan‑kevitra momba ny zava‑mahadomelina na ny homamiadana fototra izany. Ny homamiadana mahazatra iray mifandray amin'ny dermatitis exfoliative dia lymphoma T‑cell hoditra, izay mety tsy haneho soritr'aretina mandritra ny volana maromaro na taona maro aorian'ny nanombohan'ny toetry ny hoditra. Amin'ny ankapobeny, ilaina ny hopitaly amin'ny fanombanana sy ny fitsaboana voalohany. Ny marary voan'ny aretina azo avy amin'ny zava‑mahadomelina dia matetika manana fomba fijery tsara amin'ny fotoana maharitra, na dia tsy misy antony mazava aza dia mety hiverimberina sy hiala. Miankina amin'ny fizotry ny homamiadana ny vinavina ho an'ny tranga mifandray amin'ny homamiadana.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Amin'ny ankapobeny dia miseho mena miparitaka be sy mivalona mandrakotra ny 90% amin'ny vatana. Ity toe-javatra ity dia famantarana hita maso amin'ny olana ara-pahasalamana isan-karazany toy ny psoriasis, eczema, na valin'ny fanafody sasany.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Ny antony mahazatra indrindra amin'ny erythroderma dia ny fihanaky ny aretin'ny hoditra, toy ny psoriasis, ny dermatitis mifandray, ny seborrheic dermatitis, ny lichen planus, ny pityriasis rubra pilaris, na ny fanehoan‑kevitra amin'ny zava‑mahadomelina, toy ny fampiasana steroids topika. Tsy dia matetika ny fisehoan‑javy voalohany, ary matetika hita amin'ny trangan'ny lymphoma sela T hoditra. Satria zava‑dehibe ny manavaka azy amin'ny lymphoma sela T hoditra, dia atao ny biopsy.